Safety and long-term efficacy of autologous hematopoietic cell transplantation for patients with systemic sclerosis

Autologous hematopoietic cell transplantation (HCT) has been introduced for patients with severe systemic sclerosis (SSc). We aimed to assess the safety and long-term efficacy of HCT modality for severe SSc, refractory to conventional therapy, in 17 patients who were referred to our – The Joint Accr...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Eleni Gavriilaki, Despina Mallouri, Ioannis Batsis, Zoi Bousiou, Anna Vardi, Nikolaos Spyridis, Georgios Karavalakis, Alkistis kyra Panteliadou, Panagiotis Dolgyras, Christos Varelas, Vlasios I. Alevizopoulos, Panagiotis G. Asteris, Panayiotis Vlachoyiannopoulos, Damianos Sotiropoulos, Petros P. Sfikakis, Ioanna Sakellari
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2025-07-01
Serier:	Frontiers in Medicine
Fag:	cell therapy hematopoietic cell transplantation systemic sclerosis scleroderma treatment-related mortality
Online adgang:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1527779/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!